Clinical Trial Update: Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion [Phase 3]

View source ↗

Summary

Phase 3 trial update for Conbercept ophthalmic injection in macular edema due to central retinal vein occlusion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion
• Macular Edema

Drugs mentioned

• Conbercept (conbercept)

Snippet

Sponsor: Chengdu Kanghong Biotech Co., Ltd. | Conditions: Macular Edema, Central Retinal Vein Occlusion | Phase 3 | Status: COMPLETED